baber/WOPTO huggingface dataset:
Patent FI-955353-A0 (FI)
Inventor: HOCHHEIMER JOHN THOMAS
IPC: H05K1/09
Filed: 1995-11-07
Abstract: The coating compsn. comprises: (a) 30-80 wt.% silver flake coated with a lubricant comprising 6-18C linear carboxylic acid(s) or salt; (b) 1.5-4.0 wt.% completely water soluble polymer binder; (c) 0.5-8.0 wt.% completely water soluble co-solvent; and (d) solvent effect amt. of water; the percentages based on total wt. of the coating compsn.. Also claimed are: (A) a coating compsn. comprising: (i) 60-75 wt.% silver flake in a form of lamellar particles with a length of at most 15 mu m; (ii) as above; (iii) as above; (iv)' 0.3-6.0 wt.% of surfactant and defoamer additive(s); (v) 0.1-5.0 wt.% anti-settling agent; (vi) 0.1-2.0 wt.% sintering adhesive; and (vii) complementary amt. of water to total 100 wt.%; the amts. of (iii) and (vii) are in proportion to viscosity of the coating compsn. is 0.3-4.0 Pa.s.; (B) a coating compsn. comprising: (a') silver flake of 15 mu m long lamellar particles as in (i) above; (b') as above; (c') as above; (d') as above; and (e') 0.1-2.0 wt.% sintering adhesive of cupric-, cadmium-, zinc-, barium-, manganese- or aluminium-oxide, silicon dioxide, lead- or barium-borosilicate glass flit; and (C) a coating compsn. (I).
Patent FI-963585-A0 (FI)
Inventor: HENTUNEN ERKKI
IPC: H02J1/12
Filed: 1996-09-11
Abstract: An electrical system for use in isolation, the electrical system comprising a main engine (14), such as a gas turbine or a diesel engine, a generator (13) driven by the main engine (14) for generating a first alternating voltage (19), a first rectifier unit (12) for converting the first alternating voltage (19) generated by the generator (13) into a direct voltage on a DC bus (18), and at least one inverter unit (10, 15) for converting the direct voltage of the DC bus (18) into a second alternating voltage (20). The generator (13) driven by the main engine (14) for generating the first alternating voltage (19) is an asynchronous machine coupled directly to the shaft of the main engine (14), and the first rectifier unit (12) also comprises an inverter part for converting the direct voltage of the DC bus (18) into an alternating voltage with an adjustable frequency to said asynchronous machine (13) so as to use the machine as a motor.
Patent FI-981920-A0 (FI)
Inventor: SUONVIERI JUKKA
IPC: H04W16/26
Filed: 1998-09-08
Abstract: The present invention refers to a method (40) for detecting network elements relaying communications between a base station and a mobile station in cellular communication network, where the communication relayed via at least one of the said elements is detected (43) by the increase of time delay compared to the time delay of mobile stations communicating directly with the base station. The present invention refers also to a system for detecting network elements relaying communications between a base station and a mobile station in cellular communication network, which system has means for detecting communication relayed via at least one of said elements by the increase of time delay compared to the time delays of mobile stations communicating directly with the base station. The present invention refers also to a network element for cellular communication network, which element comprises a system for identifying communication relaying elements on the grounds of the communication time delays.
Patent FI-982221-A0 (FI)
Inventor: ANTONIO FRANKLIN P
IPC: H04B1/04
Filed: 1998-10-13
Abstract: A system and method for reducing radio frequency interference arising in connection with pulsed transmission over time division multiplexed communication channels. In a first embodiment, a subscriber station is nominally assigned all of the slots of each frame of a first transmit channel. By transmitting RF energy substantially continuously, the subscriber station reduces interference arising from pulsed transmission. In a second embodiment, a subscriber station is nominally assigned one or more slots of each frame of a primary channel for conventional transmission of useful information, and is also instructed to continuously transmit RF energy over an auxiliary channel at times other than during the assigned primary channel slots. In this way, interference generated in the vicinity of the subscriber station is reduced due to the substantially continuous transmission of RF energy by the subscriber station. More than one subscriber station may simultaneously utilize the auxiliary channel during reduced interference mode operation.
Patent IL-57623-A0 (IL)
Title: Bis-1,2-naphthoquinone-2-diazide sulfonic acid esters and light sensitive mixtures containing them
IPC: G03C1/72
Filed: 1979-06-22
Abstract: A positive-working light-sensitive mixture for the preparation of printing plates, in particular planographic printing plates, and photoresists is described, which comprises an alkali-soluble binder, preferably a novolak, and an o-naphthoquinone diazide of the formula <IMAGE>  (I)  in which R1, R1', R2 and R2' are identical or different and represent hydrogen, chlorine or bromine atoms, alkyl, alkoxy or alkoxyalkyl groups having 1 to 6 carbon atoms or alkenyl groups having 2 to 6 carbon atoms, R3 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, R4 represents a hydrogen atom, an optionally substituted alkyl group, the carbon chain of which can be interrupted by ether oxygen atoms, an optionally substituted cycloalkyl group having 5 to 16 carbon atoms or an optionally substituted alkenyl group having 2 to 16 carbon atoms, n represents zero or an integer from 1 to 4 and D represents a 1,2-naphthoquinone-2-diazide-sulfonyl group. The new naphthoquinone diazides are distinguished by a high solubility in organic solvents and by good reprographic properties.
Patent IL-61662-A0 (IL)
Title: Dibenzoxepine derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07D313/14
Filed: 1980-12-08
Abstract: Azatetracyclic carbonitriles of the formula    <IMAGE>  (I)  in which R represents hydrogen, lower alkyl, cycloalkyl-lower alkyl having up to 10 carbon atoms, lower alkenyl, lower alkynyl or free, etherified or esterified hydroxy-lower alkyl, and acid addition salts thereof, processes for their manufacture, pharmaceutical compositions that contain such compounds and their use. They are distinguished especially by their central nervous system-depressant, agitation-inhibitory (amphetamine-antagonistic) action. They can therefore be used as tranquillizing, anti-psychotic, agitation-inhibitory compounds for the treatment of agitated states having various causes.
Patent IL-76393-A0 (IL)
Title: Pharmaceutical parenteral formulations of dezocine
IPC: A61K47/00
Filed: 1985-09-13
Abstract: Ready-to-use parenteral formulations of dezocine contain from about 0,2 to about 2,0 percent wt/vol. dezocine; about 30 to about 45 percent wt/vol. propylene glycol; about 0,5 to about 2,0 percent wt/vol. lactic acid; buffered with a pharmaceutically acceptable base to a pH of from about 3,5 to about 5,0 and 0 to about 0,02 percent wt/vol. sodium or potassium metabisulphite, in water for injection.
Patent IL-81943-A0 (IL)
Title: Process and compounds for repairing a multi-wire electrical cable and process for electrochemically coating a metallic wire
IPC: H02G1/16
Filed: 1987-03-19
Abstract: Two process (1) and (2A) and (2B) are claimed as is the cpd. in (ii) of process (1). (1) Process for repairing a multi-wire electrical cable after exposure to water resulting in water-bridging comprises (i) opening the outer covering; (ii) distributing granules of a water-swellable, water-insoluble polymer mixed with granules of a lubricating and bond-breaking substances into the interstices for a sufficient time to dry the insulation; (iii) removing the polymer granules; and (iv) restoring the outer covering. The cpd. in (ii) is also claimed. The polymer granules are pref. 50-150 mesh and have attached carboxylate, sulphate, phosphate and/or sulphonate gps. These granules cause no electrochemical heating. The lubricating and bond-breaking substances comprise pref. 70-90 vol.% and are pref. non-silica talc or clay. (2A) Process for electrochemically coating a metallic wire having a positive ionic deposition comprises (a) prepg. a soln. of a polymer having anionic gps. and at least one non-involved cationic substance; (b) placing the wire in the soln.; (c) passing a small DC current through the soln. so that the wire is the anode, and the substance with cations is left in soln. This provides a hydrophobic insulation which is chelated on the wire, with an anionic-cationic linkage established between the polymer and the metal. (2B) Above process is the basis of another claimed process for repairing a cable carrying at least one pair of wires, e.g. telephone wires, which carry a small DC current after a short caused by water. It essentially comprises sprinkling polymer granules having anionic gps. and at least one non-involved cationic substance over isolated and sepd. wires followed by passing a small DC current through the wire.
Patent IL-93137-A0 (IL)
Title: Article with polymeric surface having permanent indicia and method for producing such indicia
IPC: G09F3/00
Filed: 1990-01-23
Abstract: Permanent white indicia are applied to a polymeric surface, preferably of a black, heat-recoverable marker sleeve for wire or cable, using an ink composition comprising a pigment that is thermally stable at a temperature of at least about 350 DEG  C., preferably titanium dioxide and a binder, such as nitrocellulose, and then heating the surface to permatize the mark. The marked article passes MIL-STD-202 in mark permanence.
Patent IL-95945-A0 (IL)
Title: Phenylacetic acid derivatives,their manufacture and their use as fungicides
IPC: A01N53/00
Filed: 1990-10-10
Abstract: Unsaturated phenylacetic acid derivatives of the general formula <IMAGE>  in which   U is =O=CH-OCH3, =N-OCH3, -N-NH-CH3, =CH2, =CH-CH3, =CH-CH2-CH3 or =CH-S-CH3 and Z<1> and Z<2> are hydrogen, halogen, trifluoromethyl, cyanide, NO2 or the optionally substituted radicals alkyl, alkenyl, aryl, alkynyl, alkoxy, aryloxy, arylalkoxy, acyloxy, hetaryl, -CO2R<1>, -CONR<2>R<3>, COR<4> or NR<5>R<6>, it also being possible for Z<1> and Z<2> to form a ring, A is in the meta- or para-position and represents (CH2)n, CH=CH, O-(CH2)n, O-(CH2)n-CO, CH2-O-CO-(CH2)n, CO-O-(CH2)n, O-CO-(CH2)n, O-(CH2)n-CO-O, O-(CH2)n+2-O, CH2-O-(CH2)n, CH2-S-(CH2)n, CH2-NR<7>-(CH2)n, CH(CN)-O-CO-(CH2)n, CH=N-(CH2)n or CH=N-O-(CH2)n,   n embraces the numbers 0 to 20, B is optionally substituted and can denote hydrogen, alkyl, cycloalkyl, aryl or hetaryl, R<1> to R<7> are hydrogen or the optionally substituted radicals alkyl, cycloalkyl, alkenyl, alkynyl, aryl, hetaryl, aralyl or cycloalkylalkyl and the acid addition products and base addition products thereof, and fungicides and insecticides containing these compounds.
Patent FI-20085402-A0 (FI)
Inventor: SEPPAENEN MIKKO
IPC: A61B/
Filed: 2008-05-02
Abstract: This document describes a fitness test application which allows the user to exercise freely (running and cycling outdoors, bicycle ergometer, rowing ergometer, treadmill) and which provides an estimate of user's fitness during and/or after the exercise. The analysis can be performed either as real-time or as post-analysis.
Patent IL-106469-A0 (IL)
Title: Novel pyridyl-and pyrimidylpiperazine derivatives
IPC: A61K31/44
Filed: 1993-07-23
Abstract: PCT No. PCT/SE93/00632 Sec. 371 Date Jan. 31, 1995 Sec. 102(e) Date Jan. 31, 1995 PCT Filed Jul. 16, 1993 PCT Pub. No. WO94/03430 PCT Pub. Date Feb. 17, 1994The present invention concerns compounds of the formula (I)   <IMAGE>   wherein Ar are the same or different and are a phenyl group, optionally substituted with fluorine, or a pyrid-4-yl group, R1 and R2 are the same or different and are selected from hydrogen or lower alkyl, n is 2 or 3, X is nitrogen or methine and A is pyrimid-2-yl or a substituted or unsubstituted pyridyl group. The compounds are useful for treating mental disorders.
Patent IL-110185-A0 (IL)
Title: Protein encapsulated insoluble gas microspheres and their preparation
IPC: A61K49/00
Filed: 1994-07-01
Abstract: Encapsulated gas microspheres having improved pressure resistance and stability are made by: mixing an aqueous solution of a filmogenic protein such as human serum albumin with a water insoluble gas such as perfluoropropane and subjecting the mixture to ultrasonic or mechanical cavitation in the absence of oxygen in an apparatus that is closed to the atmosphere.
Patent IL-132598-A0 (IL)
Title: Method for purifying lactic acid
IPC: C07C59/08
Filed: 1998-06-05
Abstract: The invention concerns a method for recuperating and purifying a lactic acid solution obtained initially from a fermentation medium or any other source, consisting in a pre-treatment to eliminate the ion loads capable of catalysing the lactic acid condensation and based on the principle of ion exchange or any other related principle, followed by at least a step of concentration at low temperature and brief retention time and at least a step of distilling the lactic acid using a thin layer process.
Patent IL-135722-A0 (IL)
Title: Intensive multidirectional phototherapy device
IPC: A61N5/06
Filed: 1998-10-30
Abstract: Disclosed is a phototherapy device for treating icterus in new-born patients, comprising a light box with at least one light source arranged in the box for illuminating the patient and a support for the patient to be placed upon which is at least partially transparent or tinted as to allow the light from the light box to expose the patient from below with respect to its direction of gravity, making it possible to expose areas having a high bilirubin concentration which tend to follow the direction of gravity.
Patent IL-148687-A0 (IL)
Title: Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds and use of said compounds in therapy, cosmetics and food
IPC: A61K8/92
Filed: 2000-09-20
Abstract: The invention concerns a method for selectively extracting furan lipids and polyhydroxylated fatty alcohols of avocado, characterised in that it comprises steps which consist in: preparing an unsaponifiable matter of avocado; then in subjecting the unsaponifiable matter of avocado to a step of molecular distillation using adjusted temperature and pressure means to obtain either a distillate comprising mainly furan lipids and polyhydroxylated fatty alcohols of avocado. Said method enables in particular to extract selectively furan lipids of avocado having a furan lipid content of more than 80 wt. %, even close to 98%.
Patent IL-150565-A0 (IL)
Title: Benzimidazole derivatives and pharmaceutical compositions containing the same
IPC: A61P3/14
Filed: 2001-01-17
Abstract: Benzimidazole derivatives and analogs (I) are new. Benzimidazole derivatives and analogs of formula (I) and their salts are new. [Image] R 1, R 2H, halo, trihalomethyl, CN, OH, 1-4C alkyl or 1-4C alkoxy, or R 1+ R 2OCH 2O, OCH 2CH 2or CH 2CH 2CH 2(all optionally C-substituted by 1-4C alkyl); A : 1-7C alkylene optionally substituted by halo, OH, NO 2, CN, Alk, OAlk (2 of which may form acetal), SAlk, SO 2Alk, 1-6C acyl, 1-6C acylamino, trihalomethyl, trihalomethoxy, oxo or phenoxy (optionally substituted by halo) and optionally interrupted by O, S, SO 2or NR 3; R 3H or Alk; Alk : 1-6C alkyl; E : COOR 3, SO 3R 3, CONHR 3, SO 2NHR 3, tetrazol-5-yl, 5-oxo-1,2,4-thiadiazol-3-yl or 5-oxo-1,2,4-oxadiazol-3-yl; G : 1-6C alkylene optionally interrupted by O, S, SO 2or NR 3and optionally substituted by halo, OH, NO 2, CN, OAlk (2 of which may form acetal), trihalomethyl, trihalomethoxy, phenyl or oxo; J : 4-10 membered heteroaryl (excluding imidazole) optionally substituted by halo, OH, NO 2, CN, Alk, OAlk (2 of which may form acetal), SAlk, SOAlk, SO 2Alk, 1-6C acyl, 1-6C acylamino, optionally substituted anilido, trihalomethyl, trihalomethoxy, phenyl, oxo, COOR 3or phenoxy (optionally substituted by halo); M : a bond or S(O) m; m : 0-2, and X : CH or N. ACTIVITY : Antiinflammatory; antiallergic; respiratory; osteopathic. MECHANISM OF ACTION : Chymase inhibitor. In assays, 4-(1-((1,4-dimethylindol-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid (Ia) exhibited an IC 50value for human chymase of 1-10 nM (no specific data is given). In oral bioavailability studies in rats, (Ia) at 30 mg/kg after 30 minutes and 4 hours had a blood concentrations of 16.1 and 6.3 mu g/ml, respectively.
Patent IL-153948-A0 (IL)
Title: Apo-2l receptor agonist and cpt-11 synergism
IPC: A61P37/00
Filed: 2001-07-27
Abstract: Methods of using effective amounts of Apo-2L receptor agonists and CPT-11 to induce apoptosis and suppress growth of cancer cells are provided.
Patent IL-157752-A0 (IL)
Title: Antimicrobial compositions
IPC: A01N43/40
Filed: 2002-04-03
Abstract: This invention concerns antimicrobial compositions that are useful for industrial applications. More specifically, it concerns antimicrobial compositions that, by combining 3-benzo[b]thiene-2-yl-5,6-dihydro-1,4,2-oxathiazine-4-oxide and one or more of 1-[[(3-iodo-2-propynyl)oxy]methoxy]-4-methoxy benzene, 1-chloro-4-[[(3-iodo-2-propynyl)oxy]methoxy] benzene, Zinc 2-pyridine thiol-1-oxide, Copper 2-pyridine thiol-1-oxide, 2-pyridine thiol-1-oxide sodium salt, 2,2-dithio-bis(pyridine-1-oxide), 2-methylthio-4-t-butyl amino-6-cyclopropyl amino-s-triazine, 3-iodo-2-propynyl butylcarbamate (IPBC), 2-(n-octyl)-3(2H)-isothiazolone (OIT), 4,5-dichloro-2-(n-octyl)-3(2H)-isothiazolone (DCOIT), 2,4,5,6-tetrachloro-1,3-benzenedicarbonitrile (chlorothalonil), 1,1-dichloro-N-[(dimethylamino)sulfonyl]-1-fluoro-N-phenyl-methanesulfenamide (dichlofluanid), or 1,1-dichloro-N-[(dimethylamino)sulfonyl]-1-fluoro-N-(4-methylphenyl)-methanesulfenamide (tolylfluanid) have the synergistic effect of these compounds.
Patent IL-166748-A0 (IL)
Title: Pyrazole derivative medicinal composition containing the same medicinal use thereof and intermediatefor production thereof
IPC: C07H17/02
Filed: 2005-02-08
Abstract: The present invention provides pyrazole derivatives represented by the general formula: <CHEM> wherein R<1> represents H, an optionally substituted C1-6 alkyl group etc.; one of Q and T represents a group represented by the general formula: <CHEM> or a group represented by the general formula: <CHEM> while the other represents an optionally substituted C1-6 alkyl group etc.; R<2> represents H, a halogen atom, OH, an optionally substituted C1-6 alkyl group etc.; X represents a single bond, O or S; Y represents a single bond, a C1-6 alkylene group etc. ; Z represents CO or SO2; R<4> and R<5> represent H, an optionally substituted C1-6 alkyl group etc.; and R<3>, R<6> and R<7> represent H, a halogen atom etc., pharmaceutically acceptable salts thereof or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT1 and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complications or obesity, and pharmaceutical compositions comprising the same, pharmaceutical uses thereof, and intermediates for production thereof.
Patent IL-180744-A0 (IL)
Title: Iterative channel and interference estimation with dedicated pilot tones for ofdma
Filed: 2007-01-16
Abstract: Estimation of channel characteristics and interference level in a time-varying multi-carrier multi-user systems is carried out concurrently. To perform the estimation, a multitude of data symbols and dedicated pilot symbols are transmitted over the channel. Next, an initial estimate value is selected for the interference level. The initial estimate value for the interference level is used together with the received pilot symbols to provide a first estimate of the channel. The first estimate of the channel is used to determine a new updated value for the interference level, which in turn, is used to update the value of the first estimate of the channel iteratively. The iterations continue until the iteratively updated values of the interference level and channel satisfy predefined limits. The data symbols and the final updated value of the channel are subsequently used to provide a second estimate for the channel.
Patent IL-183924-A0 (IL)
Title: Use of a combination of active agents in the preparation of pharmaceutical compositions
Filed: 2007-06-14
Abstract: This invention is directed towards treatments for multiple sclerosis comprising administering to a patient in need thereof a first agent, such as 2-chloro-2′-deoxyadenosine (2-CdA), that reduces the number of lymphocytes in combination with a second agent, such as an anti-alpha-4 integrin antibody, that blocks the adhesion of monocytes and leukocytes to endothelial cells. The use of 2-CdA combined with an anti-alpha-4 integrin antibody may be more effective than either treatment alone for MS. Furthermore, the combination treatment may allow for a lowering or altering the dose of one or more of the agents in order to limit any adverse effects associated with the individual agents, but maintaining the same therapeutic efficacy.
Patent IL-185183-A0 (IL)
Title: Intervertebral prosthesis comprising self-tapping fixing projections
Filed: 2007-08-09
Abstract: An intervertebral prosthesis, in particular for the cervical spine, with two attachment plates connected in an articulated manner. The attachment surfaces of the attachment plates designed for attachment to the adjacent vertebral bodies have a base surface (3) intended to bear on the surface of the vertebral bodies, and self-tapping fixing projections rising from said base surface (3) . According to the invention, these fixing projections are formed by at least one pair of ribs (4) which extend in opposite directions obliquely with respect to a predetermined implantation direction (2) and whose side faces (5) orientedmore awayfromthe implantation direction are steeper than their side faces (6) oriented more in the implantation direction. The ribs can be toothed.
Patent IL-192094-A0 (IL)
Title: Container assembly
Filed: 2008-06-12
Abstract: A container assembly for controlling rate of oxygen transfer from the atmosphere into a liquid stored in the container assembly comprising, a container (1) having a body, the walls of the body having an oxygen permeability within a predetermined range chosen for the liquid being stored, a frame (2) for supporting the container and bracing at least one of the walls of the container against bulging, a pair of access openings (3) beneath the frame for allowing entry of the tynes of a forklift, a neck (7) with an open mouth extending from an upper wall of the body, the upper wall being shaped so as to allow substantially all air to flow out of the body through the neck as the container is filled to the level of the bottom of the neck and, an outlet (4) for draining liquid from the container arranged near a bottom wall of the body.